CQ Pharmaceutical reports 18.6% profit jump, state takeover

CQ Pharmaceutical Holding reported net profit attributable to shareholders rising 18.56% to RMB 282.27 million for the first half of 2025, while operating revenue increased 3.54% to RMB 41.19 billion.

The pharmaceutical wholesale business, which accounts for 94.81% of total revenue, drove the growth as the company expanded into 14 new prefecture-level markets.

The company disclosed that its actual controller changed to the State-owned Assets Supervision and Administration Commission of the State Council, representing a shift to state ownership.